Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Rottendorf Pharma Expands into U.S. | Contract Pharma
Breaking News

Rottendorf Pharma Expands into U.S.

Chicago office, new subsidiary to serve U.S. market

Rottendorf Pharma GmbH has continued its global expansion with the addition of offices in Chicago and the establishment of the Rottendorf Pharma, Inc. subsidiary. Gordon Haines has been appointed chief executive officer of Rottendorf Pharma. Inc., which will initially focus its efforts on developing markets through business development and supply chain activities in the U.S. Manufacturing operations in Germany and Europe will initially support these efforts, with plans for a U.S.-based packaging operation. The company will keep its technical areas of formulation, development and bulk manufacturing in Europe for now.

Rottendorf has supplied products for the U.S. market for the last four years from its FDA-approved production facility in Germany. According to the company, the establishment of Rottendorf Pharma, Inc. demonstrates its commitment to expanding the U.S. market presence and providing “home-based” services to U.S./American customers. 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters